{"id":"W4377096713","doi":"10.51731/cjht.2023.655","title":"Lutetium (¹⁷⁷Lu) Vipivotide Tetraxetan (Pluvicto)","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Cabazitaxel; Prostate cancer; Medicine; Taxane; Oncology; Clinical trial; Drug; Internal medicine; Cancer; Androgen deprivation therapy; Pharmacology; Political science; Breast cancer; Health care","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006257348,0.0001710461,0.0002078587,0.0004146573,0.0001454,0.0005759378,0.0003963288,0.000431729,0.01122309],"category_scores_gemma":[0.0006234813,0.00008783305,0.0002473963,0.0004176815,0.0003503865,0.0004117531,0.0002319873,0.0005184176,0.002179814],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001189768,"about_ca_system_score_gemma":0.001438847,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01198499,"about_ca_topic_score_gemma":0.02295147,"domain_scores_codex":[0.9998398,0.00003518695,0.00001382068,0.00002631423,0.00006483182,0.00001998413],"domain_scores_gemma":[0.9998324,0.00006231909,0.00004145144,0.000007530043,0.00003729123,0.00001893201],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001055037,0.00005989205,0.001289336,0.003963585,0.00008967442,0.0003922401,0.00005674929,0.0003421382,0.02911824,0.006621469,0.05120099,0.9058106],"study_design_scores_gemma":[0.0003718301,0.001497992,0.004415129,0.001312324,0.0001689838,0.002059516,0.00008648844,0.000271376,0.03606707,0.0006807515,0.9530411,0.00002738678],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.02589658,0.8222652,0.006057414,0.005242572,0.001773847,0.0001890439,0.001592575,0.0004295708,0.1365532],"genre_scores_gemma":[0.3171165,0.4981992,0.01324331,0.008321255,0.0007501016,0.0002753688,0.003289926,0.0001891604,0.1586152],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01198499,"threshold_uncertainty_score":0.03754491,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05330637484045283,"score_gpt":0.3480798382205606,"score_spread":0.2947734633801078,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}